BSEIndia
      Close  
NOTICES
Notice No.   20230213-28   Notice Date   13 Feb 2023
Category   Trading   Segment   Equity
Subject   Opening of Offer to Buy – Acquisition Window (Delisting) for Phaarmasia Limited
Attachments   Letter of Offer_Phaamasia.pdf ;
Content

 Trading Members and Custodians are requested to note that Securities Exchange Board of India (SEBI) has issued Mechanism for acquisition of shares through Stock Exchange pursuant to Tender-Offers under Takeovers, Buy Back and De-listing, vide its circular no. CIR/CFD/POLICYCELL/1/2015 dated April 13, 2015 and no. CFD/DCR2/CIR/P/2016/131 dated Dec 09, 2016. The Exchange vide its notice no. 20170210-16 dated Feb 10, 2017, 20190207-23 dated 07 Feb 2019 and 20200528-32 dated 28 May 2020 and 20201102-43 dated 02 Nov 2020 and has issued Revised Guidelines of Mechanism for acquisition of shares through Stock Exchange pursuant to Tender-Offers under Takeovers, Buy Back and Delisting.

All Market Participants are hereby informed that an Offer for Voluntary Delisting of Equity Shares to the Public Shareholders of Phaarmasia Limited (“Target Company”) is made by Maneesh Pharmaceuticals Limited (the “Promoter Acquirer”) to acquire 18,08,228 (Eighteen Lakh Eight Thousand Two Hundred Twenty Eight only) Equity Shares representing 26.49% of face value Rs. 10.00/- (Indian Rupees Ten only) each of the total paid up equity share capital of the Company from the Public Shareholders, at the floor price of Rs.24.00/- (Indian Rupees Twenty Four only) per Equity Share through the reverse book-building process in accordance with the SEBI Delisting Regulations, from February 15, 2023 to February 21, 2023.


Letter of Offer is attached for your perusal.

Market participants are further requested to note that the details of this Offer to Buy would be available on BSE Website – www.bseindia.com.

 

Mangesh Tayde

Asst. General Manager

Listing Sales & Ops

February 13, 2023